Metagenomi Therapeutics, Inc.
MGX • NASDAQ
Metagenomi Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jian Irish, with a market cap of $52.3M.
Market Cap$52.3M
Employees236.0
CEOJian Irish
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Metagenomi Therapeutics, Inc. FAQ
Common questions about Metagenomi Therapeutics, Inc.
Metagenomi Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $5.1M.
Metagenomi Therapeutics, Inc. has approximately 236 employees.